MDNE3 — MOURA DUBEUX ENGENHARIA S/A

CNPJ 12.049.631/0001-84 · listed classes: MDNE3 · CVM code 21067

6.6P/E

1.8P/B

6.7EV/EBITDA

-5.2%FCF yield

27.5%ROE 2025

22.4%ROIC 2025

P/E, P/B and EV/EBITDA priced at the session of 2026-03-11 (R$ 32.75), the first one after the 2025 filing became public on 2026-03-11 — point-in-time, not the 31 December price.

The full history, year by year

The arrow opens the path from the figure down to the line in the regulator's file. A cell with ^! carries a caveat; a dash is a withheld figure — hover for the reason. Nothing is hidden.

indicator	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
ROE ⟶	58.4%^!	31.1%	27.3%	19.9%	12.2%	5.9%	-22.9%	-0.3%	-76.3%	-76.6%	-18.4%	8.0%	9.4%	12.4%	17.5%	27.5%
ROIC ⟶	38.6%^!	17.2%	13.2%	11.3%	8.9%	6.9%	-0.5%^!	3.6%^!	-2.4%^!	4.6%^!	-4.2%^!	5.1%	7.0%	11.4%	14.2%	22.4%
ROA ⟶	9.6%^!	5.3%	4.8%	5.3%	4.1%	2.9%	-4.9%	0.5%	-9.9%	-4.9%	-4.8%	3.6%	3.8%	5.0%	6.6%	8.6%
Gross margin ⟶	39.7%	29.0%	23.5%	28.2%	28.9%	27.7%	13.2%	28.4%	19.6%	39.7%	27.1%	36.4%	33.3%	34.7%	33.5%	34.9%
EBIT margin ⟶	33.5%	18.5%	16.1%	18.9%	17.7%	19.1%	-2.0%	14.5%	-15.2%	22.1%	-14.1%	10.0%	11.0%	14.9%	15.8%	18.9%
Net margin ⟶	26.2%	14.1%	11.3%	14.3%	11.2%	9.4%	-19.8%	1.8%	-55.1%	-24.3%	-20.3%	13.7%	13.1%	13.5%	16.0%	17.8%
Revenue growth (1y) ⟶	—	14.6%	28.8%	25.5%	3.3%	-9.0%	-23.0%	1.1%	-41.0%	13.3%	25.9%	20.7%	29.0%	44.0%	36.4%	50.1%
Revenue growth (5y CAGR) ⟶	—	—	—	—	—	5.0%	-2.8%	-1.5%	-15.3%	-13.7%	-8.1%	0.6%	5.6%	26.2%	30.9%	35.6%
Net debt/EBITDA ⟶	0.95x	3.56x	4.07x	4.40x	5.73x	7.28x	—	11.36x	—	11.94x	—	-0.90x	-1.39x	0.20x	0.41x	0.70x
Current ratio ⟶	4.39x	2.13x	1.96x	2.56x	2.89x	3.09x	1.43x	1.36x	0.68x	0.96x	2.12x	1.85x	2.78x	2.39x	2.46x	2.18x

The current year, quarter by quarter

As the company filed it in its interim report. The fourth quarter does not exist on its own in that filing — the closed year comes in the annual one, and we do not derive a Q4, so that a figure we computed never sits beside the figures the company reported. Filed on is the date the report became public, and the price is taken from it.

quarter	revenue	profit	net margin	P/E TTM	P/B	filed on
2024T1	308.4	42.2	13.7%	6.2	0.75	2024-05-09
2024T2	392.1	74.9	19.1%	5.9	0.80	2024-08-08
2024T3	501.7	89.0	17.7%	5.8	0.89	2024-11-07
2025T1	439.0	70.4	16.0%	5.0	0.87	2025-05-14
2025T2	664.9	120.3	18.1%	6.0	1.16	2025-08-13
2025T3	548.3	117.6	21.4%	7.3	1.42	2025-11-12
2026T1	627.8	155.5	24.8%	6.3	1.50	2026-05-06
2026T2	731.1	173.9	23.8%	4.4	1.08	2026-08-12

Full series, every quarter: GET /empresas/MDNE3/trimestres

Dividends per year

year	per share	payments
2025	R$ 2.3943	4
2024	R$ 0.6500	1

Piotroski F-Score 5/9 (2025) — what each criterion means.

Restated filings for this company

The regulator overwrites the old version; we keep both. Figures in R$ millions: first filing on the left, restatement on the right.

fiscal year	account	first filing	restated
2017	BPP 2.01	430.2	1,798.5
2015	BPP 2.01	312.5	595.1
2015	BPP 2.01.04	264.4	544.4
2015	BPP 2.02.01	416.6	136.7
2012	DRE 3.02	-684.6	-435.6
2012	DRE 3.01	895.0	656.9
2015	DMPL 5.03	602.3	425.8
2015	DMPL 5.07	634.5	459.7

This company appears in

Other companies in Consumer Cyclical

109 more with a page, same CVM sector — a classification of the regulator's, not ours.

Take this into your code

Everything on this page is also JSON: GET /empresas/MDNE3/indicadores. WEGE3 is open for testing without a key; for the rest, create a free key (200 calls/day, no card).

Price coverage: 1,635 sessions, 2020-02-13 → 2026-09-04 · methodology · how we verify

Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 12:12 UTC. If this does not match /saude, you are reading a cached copy.